221 related articles for article (PubMed ID: 24729609)
1. Characterization of platelet-monocyte complexes in HIV-1-infected individuals: possible role in HIV-associated neuroinflammation.
Singh MV; Davidson DC; Jackson JW; Singh VB; Silva J; Ramirez SH; Maggirwar SB
J Immunol; 2014 May; 192(10):4674-84. PubMed ID: 24729609
[TBL] [Abstract][Full Text] [Related]
2. Dyad of CD40/CD40 ligand fosters neuroinflammation at the blood-brain barrier and is regulated via JNK signaling: implications for HIV-1 encephalitis.
Ramirez SH; Fan S; Dykstra H; Reichenbach N; Del Valle L; Potula R; Phipps RP; Maggirwar SB; Persidsky Y
J Neurosci; 2010 Jul; 30(28):9454-64. PubMed ID: 20631174
[TBL] [Abstract][Full Text] [Related]
3. Frontline Science: CXCR7 mediates CD14
Veenstra M; Williams DW; Calderon TM; Anastos K; Morgello S; Berman JW
J Leukoc Biol; 2017 Nov; 102(5):1173-1185. PubMed ID: 28754798
[TBL] [Abstract][Full Text] [Related]
4. Shedding of PECAM-1 during HIV infection: a potential role for soluble PECAM-1 in the pathogenesis of NeuroAIDS.
Eugenin EA; Gamss R; Buckner C; Buono D; Klein RS; Schoenbaum EE; Calderon TM; Berman JW
J Leukoc Biol; 2006 Mar; 79(3):444-52. PubMed ID: 16507710
[TBL] [Abstract][Full Text] [Related]
5. Detection of circulating platelet-monocyte complexes in persons infected with human immunodeficiency virus type-1.
Singh MV; Davidson DC; Kiebala M; Maggirwar SB
J Virol Methods; 2012 May; 181(2):170-6. PubMed ID: 22387340
[TBL] [Abstract][Full Text] [Related]
6. JAM-A and ALCAM are therapeutic targets to inhibit diapedesis across the BBB of CD14+CD16+ monocytes in HIV-infected individuals.
Williams DW; Anastos K; Morgello S; Berman JW
J Leukoc Biol; 2015 Feb; 97(2):401-12. PubMed ID: 25420915
[TBL] [Abstract][Full Text] [Related]
7. A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis.
Persidsky Y; Stins M; Way D; Witte MH; Weinand M; Kim KS; Bock P; Gendelman HE; Fiala M
J Immunol; 1997 Apr; 158(7):3499-510. PubMed ID: 9120312
[TBL] [Abstract][Full Text] [Related]
8. Activation of peroxisome proliferator-activated receptor gamma (PPARgamma) suppresses Rho GTPases in human brain microvascular endothelial cells and inhibits adhesion and transendothelial migration of HIV-1 infected monocytes.
Ramirez SH; Heilman D; Morsey B; Potula R; Haorah J; Persidsky Y
J Immunol; 2008 Feb; 180(3):1854-65. PubMed ID: 18209083
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of CNS Viral Seeding by HIV
Veenstra M; León-Rivera R; Li M; Gama L; Clements JE; Berman JW
mBio; 2017 Oct; 8(5):. PubMed ID: 29066542
[TBL] [Abstract][Full Text] [Related]
10. Excess soluble CD40L contributes to blood brain barrier permeability in vivo: implications for HIV-associated neurocognitive disorders.
Davidson DC; Hirschman MP; Sun A; Singh MV; Kasischke K; Maggirwar SB
PLoS One; 2012; 7(12):e51793. PubMed ID: 23251626
[TBL] [Abstract][Full Text] [Related]
11. Rho-mediated regulation of tight junctions during monocyte migration across the blood-brain barrier in HIV-1 encephalitis (HIVE).
Persidsky Y; Heilman D; Haorah J; Zelivyanskaya M; Persidsky R; Weber GA; Shimokawa H; Kaibuchi K; Ikezu T
Blood; 2006 Jun; 107(12):4770-80. PubMed ID: 16478881
[TBL] [Abstract][Full Text] [Related]
12. Elevated platelet-monocyte complexes in patients with psoriatic arthritis.
Pamuk GE; Nuri Pamuk O; Orüm H; Arican O; Turgut B; Demir M
Platelets; 2009 Nov; 20(7):493-7. PubMed ID: 19852688
[TBL] [Abstract][Full Text] [Related]
13. Targeting platelet-derived soluble CD40 ligand: a new treatment strategy for HIV-associated neuroinflammation?
Davidson DC; Jackson JW; Maggirwar SB
J Neuroinflammation; 2013 Dec; 10():144. PubMed ID: 24289660
[TBL] [Abstract][Full Text] [Related]
14. Functional synergy between CD40 ligand and HIV-1 Tat contributes to inflammation: implications in HIV type 1 dementia.
Sui Z; Sniderhan LF; Schifitto G; Phipps RP; Gelbard HA; Dewhurst S; Maggirwar SB
J Immunol; 2007 Mar; 178(5):3226-36. PubMed ID: 17312171
[TBL] [Abstract][Full Text] [Related]
15. Dysfunction of brain pericytes in chronic neuroinflammation.
Persidsky Y; Hill J; Zhang M; Dykstra H; Winfield M; Reichenbach NL; Potula R; Mukherjee A; Ramirez SH; Rom S
J Cereb Blood Flow Metab; 2016 Apr; 36(4):794-807. PubMed ID: 26661157
[TBL] [Abstract][Full Text] [Related]
16. Dopamine Increases CD14
Calderon TM; Williams DW; Lopez L; Eugenin EA; Cheney L; Gaskill PJ; Veenstra M; Anastos K; Morgello S; Berman JW
J Neuroimmune Pharmacol; 2017 Jun; 12(2):353-370. PubMed ID: 28133717
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 Tat-induced platelet activation and release of CD154 contribute to HIV-1-associated autoimmune thrombocytopenia.
Wang J; Zhang W; Nardi MA; Li Z
J Thromb Haemost; 2011 Mar; 9(3):562-73. PubMed ID: 21143381
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 gp120 compromises blood-brain barrier integrity and enhances monocyte migration across blood-brain barrier: implication for viral neuropathogenesis.
Kanmogne GD; Schall K; Leibhart J; Knipe B; Gendelman HE; Persidsky Y
J Cereb Blood Flow Metab; 2007 Jan; 27(1):123-34. PubMed ID: 16685256
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 Tat induces monocyte chemoattractant protein-1-mediated monocyte transmigration across a model of the human blood-brain barrier and up-regulates CCR5 expression on human monocytes.
Weiss JM; Nath A; Major EO; Berman JW
J Immunol; 1999 Sep; 163(5):2953-9. PubMed ID: 10453044
[TBL] [Abstract][Full Text] [Related]
20. Antiplatelet activity of valproic acid contributes to decreased soluble CD40 ligand production in HIV type 1-infected individuals.
Davidson DC; Hirschman MP; Spinelli SL; Morrell CN; Schifitto G; Phipps RP; Maggirwar SB
J Immunol; 2011 Jan; 186(1):584-91. PubMed ID: 21115729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
